Drug intelligence / Profile preview

Amerigel

Development stage
Phase 4
Lead developer
Amerx Health Care Corp
Modality
Hydrogel Systems → Drug Delivery Systems, Small Molecules, Recombinant Proteins and Enzymes
Administration
Topical
01

Overview

Amerigel is a brand of topical wound care products primarily formulated as hydrogels for the management and treatment of various skin wounds and ulcers. The main active components include Oakin (oak extract), Meadowsweet extract, zinc acetate, polyethylene glycol 400/3350, and water. Some formulations also contain lidocaine HCl for pain relief. The mechanism of action involves maintaining a moist wound environment to support healing; providing antimicrobial (including bactericidal against MRSA and VRE), antifungal, anti-inflammatory effects; promoting autolytic debridement; decreasing cell membrane permeability; balancing proteins at the wound site; stimulating granulation tissue growth; and prompting wound contracture[1][5][6][8]. Indications include stage I-IV pressure ulcers, venous stasis ulcers, diabetic skin ulcers, burns (first/second degree), post-surgical incisions with dehiscence, cuts, abrasions[1][5][7]. Oakin provides tannins that draw proteins to the wound site while exerting anti-inflammatory and bactericidal properties[8]. Developed for both prescription and over-the-counter use.

Brand names
Amerigel
Other names
Amerigel Hydrogel Wound DressingAmeriGel Wound Dressing PLUSAmerigel BarrierAmerigel Care
02

Targets

PGN (Peptidoglycan)

Beyond the preview

Go deeper on Amerigel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amerigel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call